Cleveland-based Aatru Medical, LLC develops medical devices for surgical incision management, including NPSIMS, its chemical pump-based negative pressure wound therapy system. The privately held company’s device uses a patented, no-moving-parts design to provide continuous therapy for up to seven days, with an emphasis on simpler application and affordable access to care. Aatru’s leadership combines medical, scientific and technology-development experience, and the company’s clinical work has been published in PubMed Central/Cureus.
FDA 510(k) Clearance
registration
ExtriCARE USAExtriCARE USA develops negative-pressure wound therapy systems, with a singular focus on NPWT rather than a broad medical-device catalog. The company launched its first product in 2012 and builds portable, clinician-friendly pumps intended to give patients more flexible therapy, including the extriCARE 3000 and its PDAC-approved 3600 system for long-term care.
Cork Medical, LLCFounded in 2007, Cork Medical designs and manufactures medical devices for wound treatment and prevention, with a particular focus on negative pressure wound therapy. The Indianapolis company began as an NPWT and specialty-mattress distributor before building clinical and engineering teams to develop its own Nisus system, creating products shaped by clinician needs. Its manufacturing facility is certified to ISO 13485:2016 through the Medical Device Single Audit Program, and its products are distributed across the United States and internationally.COLUMBUS, OH
GWR Medical, IncFounded in 1996 in Chadds Ford, Pennsylvania, privately owned GWR Medical develops FDA-cleared topical oxygen therapy devices for hard-to-heal open wounds and burns. Its home-based TO2 treatment is paired with WoundMatrix, the company’s wound-imaging and measurement technology, to help clinicians and insurers track healing remotely. GWR says its therapy has been provided to 15,000 patients and has been used by the Department of Defense and Veterans Administration.CHADDS FORD, PA
AtriCure, IncFounded in 2000 and headquartered near Cincinnati, AtriCure develops and manufactures medical devices for treating atrial fibrillation and managing pain after surgery. Its AtriClip left atrial appendage system is the most widely sold device of its kind worldwide, while its Isolator Synergy system became the first device FDA-approved for surgical treatment of persistent Afib. With more than 1,400 employees and products sold in approximately 50 countries, AtriCure also supports clinical research and professional training around its therapies.MASON, OH